Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
Saved in:
| Title: | Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial. |
|---|---|
| Authors: | Milligan, Iain D.1, Gibani, Malick M.1, Sewell, Richard1, Clutterbuck, Elizabeth A.1, Campbell, Danielle1, Plested, Emma1, Nuthall, Elizabeth1, Voysey, Merryn2, Silva-Reyes, Laura3, Juliana McElrath, M.4, De Rosa, Stephen C.4, Frahm, Nicole4, Cohen, Kristen W.4, Shukarev, Georgi5, Orzabal, Nicola5, Duijnhoven, Wilbert van5, Truyers, Carla5, Bachmayer, Nora5, Splinter, Daniel5, Samy, Nathaly6 |
| Source: | JAMA: Journal of the American Medical Association. 4/19/2016, Vol. 315 Issue 15, p1610-1623. 14p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
